1. Yu, Gui-Ping, Huang, Bin, Chen, Guo-Qiang, Ji, Yong, Shen, Zhen-Ya. 2011. PEBP4 gene expression and its significance in invasion and metastasis of non-small cell lung cancer. In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 33, 223-8. doi:10.1007/s13277-011-0265-3. https://pubmed.ncbi.nlm.nih.gov/22076923/
2. Yu, Guiping, Zhong, Ning, Chen, Guoqiang, Huang, Bin, Wu, Song. 2014. Downregulation of PEBP4, a target of miR-34a, sensitizes drug-resistant lung cancer cells. In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 35, 10341-9. doi:10.1007/s13277-014-2284-3. https://pubmed.ncbi.nlm.nih.gov/25038915/
3. He, Hailan, Xiao, Guancheng, Hu, Xing, Zou, Xiaofeng, Zou, Junrong. 2024. Knockout of phosphatidylethanolamine binding protein4 (PEBP4) promotes chronic non-bacterial prostatitis by mediating the activation of NF-κB signaling. In Andrology, 13, 331-341. doi:10.1111/andr.13647. https://pubmed.ncbi.nlm.nih.gov/38591173/
4. Wu, Zijian, Liu, Bin, Zheng, Xuemin, Hou, Huijing, Li, Ying. . Role of the PEBP4 protein in the development and metastasis of gastric cancer. In Oncotarget, 8, 18177-18184. doi:10.18632/oncotarget.15255. https://pubmed.ncbi.nlm.nih.gov/28193908/
5. Li, Weiping, Dong, Yongchao, Zhang, Bin, Yang, Xukai, Wang, He. 2016. PEBP4 silencing inhibits hypoxia-induced epithelial-to-mesenchymal transition in prostate cancer cells. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 81, 1-6. doi:10.1016/j.biopha.2016.03.030. https://pubmed.ncbi.nlm.nih.gov/27261570/
6. Wang, Shun-Chang, Zhou, Fang, Zhou, Zhen-Yu, Chang, Liang, Ma, Ming-de. 2017. Knockdown of PEBP4 suppresses proliferation, migration and invasion of human breast cancer cells. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 90, 659-664. doi:10.1016/j.biopha.2017.03.098. https://pubmed.ncbi.nlm.nih.gov/28415045/
7. Huang, Ren-Qiang, Wang, Song-Qing, Zhu, Qing-Bao, Chen, Rui, Lu, Yi-Cheng. 2018. Knockdown of PEBP4 inhibits human glioma cell growth and invasive potential via ERK1/2 signaling pathway. In Molecular carcinogenesis, 58, 135-143. doi:10.1002/mc.22915. https://pubmed.ncbi.nlm.nih.gov/30255656/
8. Zhao, Z, Zhang, L, Yao, Q, Tao, Z. 2015. miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells. In Cancer gene therapy, 22, 108-14. doi:10.1038/cgt.2014.73. https://pubmed.ncbi.nlm.nih.gov/25721211/